CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Clinical trials for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS explained in plain language.
Never miss a new study
Get alerted when new CHRONIC RHINOSINUSITIS WITH NASAL POLYPS trials appear
Sign up with your email to follow new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection shows promise for stubborn sinus condition
Disease control CompletedThis study tested the long-term safety and effectiveness of an experimental injection called TQC2731 for adults with chronic sinusitis and nasal polyps. It involved 59 participants who had previously been in a related trial. The main goal was to see how safe the treatment was ove…
Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Simple antibiotic pill cuts nasal polyp return by Two-Thirds after surgery
Disease control CompletedThis study tested whether a low-dose antibiotic (clarithromycin) taken daily for three months could help prevent nasal polyps from growing back after surgery. It involved 100 patients who had surgery for chronic sinusitis with polyps. The group that took the antibiotic had signif…
Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Phase: NA • Sponsor: Fatima Jinnah Medical University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New treatment tested for stubborn sinus polyps
Disease control CompletedThis study tested a medication called dupilumab in Japanese adults with chronic sinusitis and nasal polyps that weren't helped enough by usual treatments like steroids or surgery. Twenty-five participants received dupilumab injections for up to 52 weeks. Researchers measured whet…
Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Head-to-Head drug showdown for stubborn sinus polyps
Disease control CompletedThis study directly compared two existing biologic drugs, dupilumab and omalizumab, to see which works better for adults with severe chronic sinusitis with nasal polyps and asthma. It involved 360 participants who had not gotten enough relief from standard treatments like nasal s…
Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New injection aims to shrink stubborn nasal polyps, reduce need for surgery
Disease control CompletedThis large, completed Phase 3 trial tested whether a new injectable medication called tezepelumab could help adults with severe, long-term sinusitis and large nasal polyps. Over 400 participants received either tezepelumab or a placebo shot every four weeks for a year, while cont…
Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Drug watch: tracking Xolair's Real-World impact on nasal polyps
Disease control CompletedThis study monitored the safety and effectiveness of Xolair in adults with chronic sinusitis and nasal polyps who weren't fully helped by standard nasal sprays. It followed 135 Korean patients in their regular doctor's visits for 24 weeks to track any side effects and see if thei…
Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New injection tested to shrink stubborn nasal polyps
Disease control CompletedThis study tested whether adding dupilumab injections to standard nasal spray therapy could better control chronic sinusitis with nasal polyps in Chinese adults. Over 24 weeks, researchers compared the drug to a placebo in 63 participants to see if it reduced polyp size and sympt…
Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
Scientists unlock secret to smell recovery in sinus patients
Knowledge-focused CompletedThis study aimed to understand how the medication dupilumab helps people with chronic sinusitis and nasal polyps regain their sense of smell. Researchers followed 60 adults already scheduled to take dupilumab, measuring inflammation and smell ability over three months. The goal w…
Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Phase: PHASE4 • Sponsor: Medical University of South Carolina • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC